FCG Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$998K Sell
2,538
-7
-0.3% -$2.59K 0.23% 63
2020
Q2
$840K Buy
2,545
+7
+0.3% +$2.03K 0.22% 59
2020
Q1
$615K Hold
2,538
0.18% 71
2019
Q4
$663K Hold
2,538
0.19% 71
2019
Q3
$690K Hold
2,538
0.21% 66
2019
Q2
$699K Hold
2,538
0.22% 65
2019
Q1
$568K Sell
2,538
-5
-0.2% -$1.03K 0.19% 70
2018
Q4
$473K Buy
2,543
+5
+0.2% +$1.02K 0.18% 74
2018
Q3
$634K Hold
2,538
0.22% 60
2018
Q2
$553K Hold
2,538
0.2% 58
2018
Q1
$486K Hold
2,538
0.17% 67
2017
Q4
$397K Sell
2,538
-35
-1% -$5.51K 0.15% 74
2017
Q3
$400K Hold
2,573
0.15% 75
2017
Q2
$415K Sell
2,573
-227
-8% -$36.9K 0.14% 82
2017
Q1
$433K Hold
2,800
0.18% 65
2016
Q4
$328K Hold
2,800
0.15% 76
2016
Q3
$316K Sell
2,800
-135
-5% -$14.2K 0.1% 89
2016
Q2
$273K Buy
2,935
+135
+5% +$11.6K 0.09% 102
2016
Q1
$219K Hold
2,800
0.08% 86
2015
Q4
$204K Hold
2,800
0.12% 78
2015
Q3
$208K Buy
+2,800
New +$201K 0.17% 74

Other funds holding IDXX

FCG Advisors's IDXX Position: Q3 2020 in Review

FCG Advisors reduced its Idexx Laboratories (IDXX) stake by 0.28% in Q3 2020, selling an estimated $2.59K and leaving 2,538 shares worth $998K. The position accounts for 0.23% of the portfolio, ranked #63.

FCG Advisors first reported a position in IDXX in Q3 2015 and has held it in 21 quarters since. 846 funds tracked by Wall St. Rank hold IDXX as of Q3 2020.

  • FCG Advisors held 2,538 shares of Idexx Laboratories worth $998K as of Q3 2020.
  • FCG Advisors sold 7 Idexx Laboratories shares in Q3 2020, an estimated $2.59K.
  • Idexx Laboratories made up 0.23% of FCG Advisors's portfolio in Q3 2020, its #63 holding.
  • FCG Advisors first reported a position in Idexx Laboratories in Q3 2015 and has held it in 21 quarters since.
  • 846 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2020.

Based on FCG Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.